Rolando M. D'angelillo

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 103 publications

SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial.

SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial.

Journal: The Lancet. Oncology

Published: February 17, 2026

Heart-Sparing Radiotherapy in Patients With Lung Cancer.

Heart-Sparing Radiotherapy in Patients With Lung Cancer.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: February 10, 2026

Impact of BRCA in patients undergoing abiraterone ± stereotactic body radiotherapy: the ARTO trial.

Impact of BRCA in patients undergoing abiraterone ± stereotactic body radiotherapy: the ARTO trial.

Journal: BJU international

Published: December 15, 2025

Biochemical recurrence after radical prostatectomy: Where do we stand to?

Biochemical recurrence after radical prostatectomy: Where do we stand to?

Journal: Prostate cancer and prostatic diseases

Published: December 12, 2025

Clusters of Anthropometric Features in Colorectal Cancer Patients with Synchronous Metastases and Their Association with Overall Survival and RAS Mutation.

Clusters of Anthropometric Features in Colorectal Cancer Patients with Synchronous Metastases and Their Association with Overall Survival and RAS Mutation.

Journal: Journal of gastrointestinal cancer

Published: August 14, 2025

Clinical Value of Bone Radiotherapy in a Prospective Cohort of Metastatic Breast Cancer Treated with Anti-CDK4/6.

Clinical Value of Bone Radiotherapy in a Prospective Cohort of Metastatic Breast Cancer Treated with Anti-CDK4/6.

Journal: Journal of clinical medicine

Published: May 11, 2025

Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO).

Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 11, 2025

Girentuximab imaging in renal cancer: diamond in the rough or just ZIRCON?

Girentuximab imaging in renal cancer: diamond in the rough or just ZIRCON?

Journal: Expert review of anticancer therapy

Published: January 15, 2025

Navigating the Complexity of Cerebral Prophylaxis: A Path Worth Taking?

Navigating the Complexity of Cerebral Prophylaxis: A Path Worth Taking?

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: December 31, 2024

Durvalumab in Small-Cell Lung Cancer.

Durvalumab in Small-Cell Lung Cancer.

Journal: The New England journal of medicine

Published: December 18, 2024

Breast CancerTrastuzumab-deruxtecan and radiotherapy: a safety sub-analysis of combart prospective cohort study.

Breast CancerTrastuzumab-deruxtecan and radiotherapy: a safety sub-analysis of combart prospective cohort study.

Journal: The oncologist

Published: December 10, 2024

Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719).

Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719).

Journal: Prostate cancer and prostatic diseases

Published: November 28, 2024

Showing 1-12 of 103

Last Updated: 09/26/2026